生物标志物
腰椎穿刺
医学
疾病
诊断生物标志物
神经影像学
生物标志物发现
脑脊液
病理
诊断准确性
放射科
蛋白质组学
精神科
生物
生物化学
基因
作者
Shun Hu,Changwen Yang,Haiming Luo
标识
DOI:10.1016/j.bios.2022.114278
摘要
Alzheimer's disease (AD) is a neurodegenerative disease that causes cognitive impairments in areas such as memory, language, and reasoning. Currently, a definitive diagnosis of AD is based on histological examination of brain specimens. Hence, it is imperative to develop practical AD detection and diagnostic tools. Blood tests are less invasive, more accessible than lumbar puncture for cerebrospinal fluid collection, and are an ideal source of biomarkers. Various detection techniques related to AD biomarkers have emerged, and have been used in the detection of AD blood samples. However, to improve the diagnostic accuracy of AD blood testing in clinical practice, basic research needs more detailed guidelines to determine how to implement the use of biomarkers in diagnostic procedures. Therefore, combining blood biomarker detection with imaging markers may help improve the accuracy of AD diagnosis. In this review, we discuss the development trend of AD-related blood biomarker detection technologies including optoelectrical analysis platforms, and look forward to the development prospects of joint detection with optoelectronic and imaging technologies in clinical diagnosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI